Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: The TAX 326 Study GroupFOSSELLA, Frank; PEREIRA, Jose R; MILLWARD, Michael et al.Journal of clinical oncology. 2003, Vol 21, Num 16, pp 3016-3024, issn 0732-183X, 9 p.Article

DNA Repair Biomarkers Predict Response to Neoadjuvant Chemoradiotherapy in Esophageal CancerALEXANDER, Brian M; XIAO ZHE WANG; NIEMIERKO, Andrzej et al.International journal of radiation oncology, biology, physics. 2012, Vol 83, Num 1, pp 164-171, issn 0360-3016, 8 p.Article

Maintenance treatment of advanced non-small-cell lung cancer: Results of an International Expert Panel Meeting of the Italian Association of Thoracic OncologyGRIDELLI, Cesare; DE MARINIS, Filippo; PIRKER, Robert et al.Lung cancer. 2012, Vol 76, Num 3, pp 269-279, issn 0169-5002, 11 p.Article

Phase I clinical trial of bortezomib in combination with gemcitabine in patients with advanced solid tumorsRYAN, David P; APPLEMAN, Leonard J; CUSACK, James et al.Cancer. 2006, Vol 107, Num 10, pp 2482-2489, issn 0008-543X, 8 p.Article